Manufacturer Won't Sell Drug for Use in Executions
Setback for states looking for alternatives to other drugs that companies have stopped selling to them
Setback for states looking for alternatives to other drugs that companies have stopped selling to them
The CEO of the Gurenthal Group apologized for manufacturing an anti-morning sickness pill that led to thousands of birth defects
Janssen promoted antipsychotic drug as also helping with anxiety and anger management
Years of trials and tests still needed.
A joint Congressional investigation has found that some US pharmacies use the "gray market" to increase profits by thousands of percent.
A dispatch on the value of failed drugs, new vaccines against superbugs, and the prospect of a molecular stethoscope.
Consumers, not bureaucrats, should make healthcare decisions.
A final dispatch from the Open Science Summit.
Do you care about free minds and free markets? Sign up to get the biggest stories from Reason in your inbox every afternoon.
This modal will close in 10